SERTAD4-AS1: Potential Drug Targets Or Biomarkers for Various Diseases

Target Name: SERTAD4-AS1

NCBI ID: G574036

SERTAD4-AS1

Other Name(s): C1orf133 | SERTAD4 antisense RNA 1

SERTAD4-AS1: Potential Drug Targets Or Biomarkers for Various Diseases

SERTAD4-AS1 (C1orf133) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SERTAD4 family, which is known for its role in intracellular signaling. SERTAD4-AS1 has been shown to play a role in a variety of physiological processes, including cell signaling, inflammation, and fibrosis. As a result, it has potential as a drug target or biomarker for a variety of diseases.

One of the key functions of SERTAD4-AS1 is its role in intracellular signaling. SERTAD4-AS1 is a member of the SERTAD4 family, which is known for its role in intracellular signaling. This family of proteins are involved in a variety of signaling pathways, including cell signaling, DNA replication, and stress response. SERTAD4-AS1 is involved in these signaling pathways by interacting with other proteins, including SERTAD4, which is a key regulator of these signaling pathways.

SERTAD4-AS1 has been shown to play a role in a variety of physiological processes, including cell signaling, inflammation, and fibrosis. For example, SERTAD4-AS1 has been shown to be involved in the regulation of cell proliferation and differentiation. In addition, SERTAD4-AS1 has been shown to play a role in the regulation of inflammation and fibrosis. This is important because these processes are often associated with a variety of diseases, including cancer, cardiovascular disease, and diabetes.

Another function of SERTAD4-AS1 is its role in cell signaling. SERTAD4-AS1 is involved in a variety of signaling pathways, including the regulation of cell signaling, protein synthesis, and DNA replication. This is important because these processes are often involved in the development and progression of diseases. For example, SERTAD4-AS1 has been shown to play a role in the regulation of cancer cell signaling, which is important for the development and progression of cancer.

In addition, SERTAD4-AS1 has been shown to play a role in the regulation of protein synthesis. This is important because protein synthesis is often involved in the development and progression of diseases. For example, SERTAD4-AS1 has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, which are involved in a variety of diseases, including cancer, cardiovascular disease, and diabetes.

Finally, SERTAD4-AS1 has been shown to play a role in the regulation of DNA replication. This is important because DNA replication is often involved in the development and progression of diseases. For example, SERTAD4-AS1 has been shown to play a role in the regulation of the production of tumor suppressor proteins, which are important for the development and progression of cancer.

In conclusion, SERTAD4-AS1 is a protein that is involved in a variety of physiological processes, including cell signaling, inflammation, and fibrosis. As a result, it has potential as a drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of SERTAD4-AS1 in these processes and to develop effective treatments for these diseases.

Protein Name: SERTAD4 Antisense RNA 1

The "SERTAD4-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SERTAD4-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets